In this study, the results proved that after treatment, the serum CA125 and CEA levels were significantly lower in the combined group than in the single chemotherapy group (P < 0.001), indicating that the combined treatment could effectively kill the tumor cells and reduce tumor burden. This evidence concerns the gene CEACAM5 and neoplasm.